Bakytzhan Amangeldinovna Issakhanova

Bakytzhan Amangeldinovna Issakhanova

Auto-generated profile, based on publicly available information

Bakytzhan Amangeldinovna Issakhanova

Department of Anatomic Pathology, RSE “Medical Centre Hospital of the President’s Affairs Administration of the Republic of Kazakhstan”, Astana, KAZAKHSTAN

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2022 in Electronic Journal of General Medicine
Verified
Journal Article
Open access
PDF file
NSNasrulla Shanazarov
Nasrulla Shanazarov
VBValery Benberin
Valery Benberin
SZSergey Zinchenko
Sergey Zinchenko
FNFatima Nalgieva
Fatima Nalgieva
NMNiyaz Muratov
Niyaz Muratov
TTTokhirzhan Tashpulatov
Tokhirzhan Tashpulatov
This article presents a clinical observation of successful treatment of a patient with multiple cylindroma of the scalp and trunk using photodynamic therapy (PDT) after radiotherapy. The first masses were found in 2008, at the same time they were surgically removed. There has been a progression of the process since 2019 - multiple masses on the scalp and trunk. There was another visit to doctors. After verification of diagnosis radiation therapy was received. However, soon after the treatment, the appearance of new and growth of existing foci has been noted. A multistage PDT with good clinical and cosmetic effect was carried out at Medical Centre Hospital of President’s Affairs Administration of the Republic of Kazakhstan.

5 May 2026 in Electronic Journal of General Medicine
Verified
Journal Article
Closed access
AUArshat Urazbaev
Arshat Urazbaev
BIBakytzhan Amangeldinovna Issakhanova
Bakytzhan Amangeldinovna Issakhanova
Zhanas BaimagambetZhanas Baimagambet
Zhanas Baimagambet
ZRZamart Ramazanova
Zamart Ramazanova
YBYeldar Baiken
Yeldar Baiken
Askhat MyngbayAskhat Myngbay
Askhat Myngbay
Objectives: Automation of quantitative analysis of breast cancer (BC) immunohistochemistry (IHC) specimens is important to optimize pathologists’ workflow and improve diagnostic reproducibility. This is especially important in low- and middle-income countries where there is a shortage of highly trained pathologists. However, existing approaches face challenges in implementing fully automated quantitative IHC due to the difficulty of both delineating tumor areas, including discrete areas, especially in IHC slides with poor quality. Moreover, accurate identification of invasive carcinoma areas and accurate quantification of positive and negative cells in the specimen are critical for quantitative analysis. Methods and results: This study presents a method to automatically identify types of carcinoma areas in whole slide IHC images of BC, focusing on quantifying IHC images on realms of Kazakhstan. The used model is a combination of morphological characteristics and boundary features, which provides high accuracy of segmentation of tumor zones of images of mild and low quality. We used several methods includes convolutional neural network based on the Keras framework, k-nearest neighbors machine learning methods, and self-developed image analysis methods. The developed model showed high accuracy, where the results corresponded to the diagnoses of pathologists. As expected, the method proved to be ineffective when applied to severely degraded slides, such as those with insufficient staining or inadequate washing. Slides of inferior quality were excluded from analysis, which negatively affected the statistical robustness. On slides of moderate quality, the reliability of nucleus segmentation dropped significantly. Conclusions: The combination of models we used showed high accuracy in differentiating BC cells between the basal-like subtype of BC and its invasiveness and recurrence in Kazakhstan. However, IHC specimens with low DPI or low-quality IHC need further optimizations and improvements in algorithm design. The main issue can be considered methodological differences between the approaches of AI and humans: AI operates in a large number of cases (more than 10,000), yet its accuracy is relatively low. In contrast, humans work with a much smaller number of cases but achieve a level of precision that AI cannot currently match. This discrepancy necessitates a revision of the methodology of IHC analysis for AI, including the development of new requirements, methods, and thresholds from scratch. This approach provides analysis of the entire area of the slide, increases the speed of interpretation of IHC results, and reduces human errors in diagnosis, especially in low- and middle-income countries.